1 min read
Add as a preferred source on GoogleCVS Health Raises 2026 GAAP EPS Floor After Q3 Earnings Beat
The company set its GAAP diluted EPS outlook at at least $6.98, replacing a range of $6.84 to $7.04. Third-quarter revenue rose 5.3% year over year to $108.4 billion.
CVS Health raised its 2026 GAAP diluted earnings-per-share outlook to at least $6.98, replacing a range of $6.84 to $7.04. The company’s third-quarter Non-GAAP EPS was $2.09, beating estimates by 44 cents.
Revenue totaled $108.4 billion, $3.71 billion above forecasts and up 5.3% from a year earlier. Non-GAAP EPS is a per-share earnings measure calculated using a company’s non-GAAP methodology.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.